These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9713290)

  • 1. New drugs for prostate cancer?
    Waxman J; Roylance R
    Eur J Cancer; 1998 Mar; 34(4):437. PubMed ID: 9713290
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostate cancer drugs. Making sense of the options.
    Mayo Clin Health Lett; 2003 Aug; 21(8):4-5. PubMed ID: 12971308
    [No Abstract]   [Full Text] [Related]  

  • 3. Choosing a prostate cancer drug.
    Baker H
    Br J Nurs; 2014 Sep 11-24; 23(16):S14, S16. PubMed ID: 25203849
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.
    Pitts WR
    J Urol; 2003 Dec; 170(6 Pt 1):2392-3; author reply 2393-4. PubMed ID: 14634434
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple intracrine hormonal targets in the prostate: opportunities and challenges.
    Labrie F
    BJU Int; 2007 Jul; 100 Suppl 2():48-51. PubMed ID: 17594360
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
    Koutsilieris M; Dimopoulos T; Milathianakis C; Bogdanos J; Karamanolakis D; Pissimissis N; Halapas A; Lembessis P; Papaioannou A; Sourla A
    BJU Int; 2007 Jul; 100 Suppl 2():60-2. PubMed ID: 17594363
    [No Abstract]   [Full Text] [Related]  

  • 7. Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer.
    Kittai AS; Blank J; Graff JN
    Oncology (Williston Park); 2018 Dec; 32(12):599-602, 604-6. PubMed ID: 30632129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New molecules and treatment modulation in advanced prostatic cancer.
    Mahler C; Verhelst J; Denis L
    Acta Urol Belg; 1996 May; 64(2):95-8. PubMed ID: 8701825
    [No Abstract]   [Full Text] [Related]  

  • 9. Advanced prostate cancer. Hormonal treatment.
    de la Haba-Rodríguez J
    Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacotherapy for prostate cancer: the role of hormonal treatment.
    Shahani R; Fleshner NE; Zlotta AR
    Discov Med; 2007 Aug; 7(39):118-24. PubMed ID: 18093474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal treatment of prostate cancer.
    Garnick MB
    N Engl J Med; 1999 Mar; 340(10):812-3. PubMed ID: 10075531
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonsteroidal anti-androgens: role in treating advanced prostate cancer.
    Newton M; Kosier JH
    Urol Nurs; 1998 Mar; 18(1):56-7, 83. PubMed ID: 9582897
    [No Abstract]   [Full Text] [Related]  

  • 13. 'Clandestine' prostate cancer haunts.
    Chapman B
    CAP Today; 1996 Feb; 10(2):1, 34-6, 38 passim. PubMed ID: 10160261
    [No Abstract]   [Full Text] [Related]  

  • 14. Complete hormonal blockage--antiandrogens.
    Bierkens AF; Debruyne FM
    Acta Urol Belg; 1996 May; 64(2):77-9. PubMed ID: 8701818
    [No Abstract]   [Full Text] [Related]  

  • 15. Androgen deprivation therapy and cardiovascular risk.
    Rees J
    Practitioner; 2015 Sep; 259(1785):5. PubMed ID: 26591651
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy and prostate cancer.
    Dacker R
    Radiol Technol; 1997; 68(3):194-5. PubMed ID: 9008013
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of hormonotherapy in the treatment of metastatic prostate cancer].
    Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S332-7. PubMed ID: 19070812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in hormonal therapy for advanced prostate cancer.
    Oottamasathien S; Crawford ED
    Oncology (Williston Park); 2003 Aug; 17(8):1047-52; discussion 1054-8. PubMed ID: 12966672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced cancer of the prostate.
    Orovan WL
    Can J Surg; 1989 Sep; 32(5):315-6. PubMed ID: 2670160
    [No Abstract]   [Full Text] [Related]  

  • 20. Twenty years of controversy surrounding combined androgen blockade for advanced prostate cancer.
    Moul JW
    Cancer; 2009 Aug; 115(15):3376-8. PubMed ID: 19484788
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.